Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MITOXANTRONE for Diffuse large b-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 201 adverse event reports in the FDA FAERS database where MITOXANTRONE was used for Diffuse large b-cell lymphoma.

Most Reported Side Effects for MITOXANTRONE

Side Effect Reports % Deaths Hosp.
Febrile neutropenia 668 16.0% 87 403
Off label use 368 8.8% 82 142
Neutropenia 296 7.1% 76 144
Drug ineffective 293 7.0% 79 119
Thrombocytopenia 256 6.1% 66 128
Sepsis 240 5.8% 94 98
Pyrexia 214 5.1% 46 125
Product use in unapproved indication 177 4.3% 53 58
Disease progression 173 4.2% 58 42
Acute myeloid leukaemia 167 4.0% 78 43
Pneumonia 157 3.8% 76 71
Infection 153 3.7% 72 37
Pancytopenia 148 3.6% 24 57
Myelodysplastic syndrome 139 3.3% 35 25
Septic shock 133 3.2% 57 98

Other Indications for MITOXANTRONE

Acute myeloid leukaemia (1,248) Acute lymphocytic leukaemia (414) Product used for unknown indication (183) Acute promyelocytic leukaemia (158) B-cell lymphoma (125) Multiple sclerosis (112) Non-hodgkin's lymphoma (104) B-cell type acute leukaemia (101) Acute lymphocytic leukaemia recurrent (89) B precursor type acute leukaemia (77)

Other Drugs Used for Diffuse large b-cell lymphoma

RITUXIMAB (22,275) CYCLOPHOSPHAMIDE (16,598) DOXORUBICIN (15,213) VINCRISTINE (14,922) PREDNISONE (11,266) LENALIDOMIDE (7,858) ETOPOSIDE (4,698) PREDNISOLONE (4,086) CYTARABINE (3,857) DEXAMETHASONE (3,696)

Related Pages

MITOXANTRONE Full Profile All Diffuse large b-cell lymphoma Drugs MITOXANTRONE Demographics MITOXANTRONE Timeline